Long-term biochemical disease-free and cancer-specific survival following anatomic radical retropubic prostatectomy. The 15-year Johns Hopkins experience.

By Misop Han, Alan W. Partin, C. Pound, Jonathan I. Epstein, P. Walsh. Urologic clinics of North America, 2001

1,074 citations recorded by the source corpus.

Subfields: Internal Medicine, Pulmonary and Respiratory Medicine

View Paper: https://www.semanticscholar.org/paper/6d1da601c520028d14d8da2f5e6490812c3bfa27

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

In Pulmonary and Respiratory Medicine

1. A. Heidenreich
2. Michel Bolla
3. N. Mottet
4. J. Bellmunt
5. V. Matveev
6. Steven Joniau
7. F. Zattoni
8. Thomas Wiegel

Citations in the corpus

• Guidelines on Prostate Cancer (2013, background): “For suspicious lesions in biopsies, diagnostic uncertainty may often be resolved by intradepartmental consultation and a second opinion from an external institution (39).”
• Retropubic, laparoscopic, and robot-assisted radical prostatectomy: a systematic review and cumulative analysis of comparative studies. (2009, neutral): “Han et al [88] Johns Hopkins, Baltimore, MD 2404”
• Salvage radiotherapy for recurrent prostate cancer after radical prostatectomy. (2004, neutral): “Persistent detectable PSA level after radical prostatectomy 160 (32)”
• Cancer progression and survival rates following anatomical radical retropubic prostatectomy in 3,478 consecutive patients: long-term results. (2004, neutral): “001 cT1a/b 74 (11) 38 (1) 112 (3) cT1c 42 (6) 1,732 (62) 1,774 (51) cT2a 222 (34) 353 (13) 575 (17) cT2b/c 311 (47) 664 (24) 975 (28) cT3 6 (1) 28 (1) 34 (1) No.”